Erina E V, Ozokvo G I
Kardiologiia. 1978 Sep;18(9):105-11.
Apressine, obsidan and a combination of these two drugs were used for treating 44 patients suffering from hypertension, mainly stage IIB. When apressine was used to treat patients with the hypodynamic type of circulation, arterial pressure decreased due to considerable diminution of the arterial tone. Tachycardia developed simultaneously and the cardiac output increased, which restrained the hypotensive effect of apressine. The addition of the beta-blocking agent obsidan corrected, while its preliminary prescription prevented the development of the noted reflex stimulation of cardiac activity. This made it possible for the main valuable properties of apressine to become manifest, namely those which reduced the tone of the arteries and produced the hypotensive effect. Small doses of apressine and of the beta-blocking agent may be used and prolonged treatment applied with no side-effects.
使用阿普加压素、奥昔坦及二者的联合用药治疗了44例高血压患者,主要为ⅡB期患者。当用阿普加压素治疗循环动力不足型患者时,动脉压因动脉张力显著降低而下降。同时出现心动过速且心输出量增加,这限制了阿普加压素的降压效果。加用β受体阻滞剂奥昔坦可纠正这种情况,而预先使用奥昔坦则可防止上述心脏活动反射性刺激的发生。这使得阿普加压素的主要重要特性得以显现,即降低动脉张力并产生降压作用。可使用小剂量的阿普加压素和β受体阻滞剂,并进行长期治疗,且无副作用。